FTC effort to stop Amgen’s Horizon takeover faces uphill fight

By Diane Bartz WASHINGTON (Reuters) – The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen Inc’s $27.8 billion acquisition of Horizon Therapeutics with an untested argument before a Trump-appointed judge, three antitrust experts said. Furthermore, the FTC’s complaint, unsealed late Tuesday, expresses concern about deals struck between drug companies that…

Read More

AstraZeneca’s China boss says drugmaker will seek to “love the Communist Party”

By Joe Cash and Brenda Goh BEIJING (Reuters) – Global drugmaker AstraZeneca will seek to be a patriotic company in China that “loves the Communist Party”, its China president said at an event on Friday. Wang Lei, who is also the company’s global executive vice president, made the comments at an event in the eastern…

Read More

Netherlands to ban inland vessels from discharging toxic fumes

AMSTERDAM (Reuters) – The Netherlands is banning inland vessels from discharging toxic fumes from July 2024, Minister of Infrastructure and Water Management Mark Harber announced this week. The ban will cover seven types of substances including carcinogenic benzene, gasoline and mixtures of petroleum and benzene. Countries along the river Rhine agreed in 2017 to jointly…

Read More

Amputees could feel warmth of human touch with new bionic technology

By Cecile Mantovani and Denis Balibouse GENEVA (Reuters) – Fabrizio Fidati, who lost his right hand in an accident 25 years ago, had not experienced the sensation of temperature in his missing digits until trials for a bionic technology unlocked the cool of iced water and heat of a stove burner for him. Eventually, the…

Read More

US FDA panel backs Pfizer’s maternal RSV vaccine for protecting infants

By Raghav Mahobe and Mariam Sunny (Reuters) -Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc’s experimental respiratory syncytial virus (RSV) vaccine, boosting its chances of becoming the first available maternal shot to protect babies from the illness. The FDA’s advisory committee voted unanimously that available…

Read More

U.S. FDA panel backs Pfizer’s RSV vaccine for protecting infants

(Reuters) – Advisers to the U.S. Food and Drug Administration on Thursday backed the safety and effectiveness of Pfizer Inc’s experimental respiratory syncytial virus (RSV) vaccine, boosting its chances of becoming the first available maternal shot to protect babies from the illness. The FDA’s advisory committee voted unanimously that available data supported the vaccine’s efficacy…

Read More

U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents

By John Kruzel WASHINGTON (Reuters) -The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to revive patents on its cholesterol-lowering drug Repatha in a legal clash with French rival Sanofi SA. The 9-0 ruling upheld a lower court’s decision that had invalidated Amgen’s patents on the grounds that the Thousand Oaks,…

Read More

Near Ukraine’s southern frontline, medics brave rockets to treat soldiers

By Max Hunder ZAPORIZHZHIA REGION, Ukraine (Reuters) – As the doctor prepared to administer an injection, the loud thud of an artillery shell in the distance broke the silence in the operating room. The staff at this emergency medical treatment point for soldiers near the Zaporizhzhia frontline in Ukraine’s south, aren’t fazed by the danger….

Read More